abstract |
The invention relates to a monoclonal antibody against a membrane protein on human cells which, when bound to human cells which have a TNF receptor, at least largely neutralizes the known effects of TNFα and / or TNFβ, and modified antibodies, methods of obtaining and using them as a medicine. |